Main content


Insight

Establishing unfairly high prices: The implications of the CAT's judgment in Flynn and Pfizer v Competition and Markets Authority

Article which looks at the the Pfizer/Flynn case at the Competition Appeal Tribunal published in the Bio-Science Law Review (Volume 17, Issue 1), by Lawtext Publishing Limited